VytronUS, Inc. Raises $49 Million in Series C Financing

SUNNYVALE, Calif., July 29, 2016 -- (Healthcare Sales & Marketing Network) -- VytronUS, Inc. ("VytronUS"), a privately held medical device company developing novel technologies for the treatment of cardiac arrhythmias, announced today that it ha... Devices, Cardiology, Venture CapitalVytronUS, Low-Intensity Collimated Ultrasound, LICU, atrial fibrillation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news